Wave of compounded obesity drugs challenges Novo Nordisk in the US

The United States market for weight-loss medications is swamped with less expensive replicas, which currently make up about 20% of the marketplace.

发布者:BY ULRICH QUISTGAARD,转转请注明出处:https://robotalks.cn/wave-of-compounded-obesity-drugs-challenges-novo-nordisk-in-the-us/

(0)
上一篇 4 10 月, 2024 11:28 下午
下一篇 4 10 月, 2024 11:28 下午

相关推荐

发表回复

您的电子邮箱地址不会被公开。 必填项已用 * 标注

联系我们

400-800-8888

在线咨询: QQ交谈

邮件:admin@example.com

工作时间:周一至周五,9:30-18:30,节假日休息

关注微信
社群的价值在于通过分享与互动,让想法产生更多想法,创新激发更多创新。